Clinical Trials Directory

Trials / Terminated

TerminatedNCT03752372

Microbiome Alterations in IL10RA-deficient Patients After HSCT

Longitudinal Development of Intestinal Microbiome in IL10RA-deficient Patients After Hematopoietic Stem Cell Transplantation

Status
Terminated
Phase
Study type
Observational
Enrollment
13 (actual)
Sponsor
Children's Hospital of Fudan University · Academic / Other
Sex
All
Age
1 Day – 6 Years
Healthy volunteers
Accepted

Summary

To elucidate the longitudinal development of intestinal microbiota in patients with IL10RA deficiency after hematopoietic stem cell transplantation (HSCT). The investigators planned to collect fecal samples from IL10RA-deficient patients who received HSCT. Samples were collected more than once every three days after engraftment in lamina flow ward and at least once a week before discharge. Microbial DNA was extracted from the fecal samples. And all analysis was based on the next generation sequencing data.

Detailed description

Hematopoietic stem cell transplantation is considered the only curative therapy for patients with interleukin-10 receptor-A(IL10RA) deficiency. The investigators aimed to collect the fecal samples of these patients throughout the conditioning, transplantation until discharge, providing a dense insight into the longitudinal development of intestinal microbiota.

Conditions

Interventions

TypeNameDescription
PROCEDUREhematopoietic stem cell transplantation1. Reduced intensity conditioning(RIC) chemotherapy regimen before transplantation 2. All patients were cared for in single rooms ventilated with a highly effective particulate air filtration system. All patients received intravenous immunoglobulin and antimicrobial prophylaxis, which included antiviral, antifungal, and Pneumocystis jirovecii prophylaxis with ganciclovir and micafungin, as per routine clinical practice before transplantation. 3. Umbilical cord blood transplantation

Timeline

Start date
2017-10-01
Primary completion
2020-02-28
Completion
2020-02-28
First posted
2018-11-26
Last updated
2020-08-12

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT03752372. Inclusion in this directory is not an endorsement.